<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03302767</url>
  </required_header>
  <id_info>
    <org_study_id>IB2017-03</org_study_id>
    <secondary_id>2017‐A01251‐52</secondary_id>
    <nct_id>NCT03302767</nct_id>
  </id_info>
  <brief_title>CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology</brief_title>
  <acronym>CAP'ONCO</acronym>
  <official_title>CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Bergonié</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Bergonié</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This patient support system is designed to help patients regain their professional activity
      after their treatment. It's a 3-Axis neuropsycho-social synergy on 3 axes:

        -  A weekly pluridisciplinary consultation in tandem (Social worker + Psychologist /
           Neuropsychologist)

        -  Monthly information meetings and workshops (TIC'Onco reunions: collective information
           times and Cogit'Onco workshops: cognitive workshops

        -  An information booklet &quot;Prepare the work return&quot; The aim of this research is to evaluate
           efficiency in term of quality of life improvement linked to work status, utility,
           feasibility and patients' satisfaction.

      The aim of this research is to evaluate efficiency in term of quality of life improvement
      linked to work status, utility, feasibility and patients' satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unmet need characterize in 4 points:

        -  Cancer and survival: challenges for cancer patients who want to work while being treated

        -  Cancer and career: Job instability for cancer patients

        -  Difficulties and isolation of patients due to a lack of coordination between healthcare
           professionals and colleagues/management

        -  Post-treatment cognitive troubles stress and hindered patient return to employment:
           chemo brain This research-action will propose and evaluate a concrete device: To
           maintain a professional activity with the support of CAP'Onco during treatment, to
           balance between quality of life, managing the &quot;cancer event&quot; and the psychosocial
           consequences for professional experience, to provide an early, durable and multimodal
           support to improve work keeping and anticipate return to employment
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 7, 2017</start_date>
  <completion_date type="Anticipated">June 27, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 27, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>To complete</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At baseline</time_frame>
    <description>QLQ-C30 version3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tiredness</measure>
    <time_frame>At baseline</time_frame>
    <description>Piper MFI-20 revised scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxio-depressive troubles</measure>
    <time_frame>At baseline</time_frame>
    <description>Hospital Anxiety and Depression scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive complaints</measure>
    <time_frame>At baseline</time_frame>
    <description>French FACT-Cog version 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Career motivation</measure>
    <time_frame>At baseline</time_frame>
    <description>scale constructed for the needs of this exploratory research. This tool has for vocation a later validation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction questionnaire for TIC and Cogit'Onco</measure>
    <time_frame>At baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>General satisfaction questionnaire</measure>
    <time_frame>At baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At 5 months</time_frame>
    <description>QLQ-C30 version3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tiredness</measure>
    <time_frame>At 5 months</time_frame>
    <description>Piper MFI-20 revised scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxio-depressive troubles</measure>
    <time_frame>At 5 months</time_frame>
    <description>Hospital Anxiety and Depression scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive complaints</measure>
    <time_frame>At 5 months</time_frame>
    <description>French FACT-Cog version 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Career motivation</measure>
    <time_frame>At 5 months</time_frame>
    <description>scale constructed for the needs of this exploratory research. This tool has for vocation a later validation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction questionnaire for TIC and Cogit'Onco</measure>
    <time_frame>At 5 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>General satisfaction questionnaire</measure>
    <time_frame>At 5 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Alertness</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1) Zimmerman et Fimm (1994) French adaptation M.Leclercq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Substained Attention/Concentration</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1) Zimmerman et Fimm (1994) French adaptation M.Leclercq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Divided attention</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1) Zimmerman et Fimm (1994) French adaptation M.Leclercq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive flexibility.1</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1) Zimmerman et Fimm (1994) French adaptation M.Leclercq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive flexibility.2</measure>
    <time_frame>At baseline</time_frame>
    <description>Trail Making Test - GREFREX (2001)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibition / control.1</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1) Zimmerman et Fimm (1994) French adaptation M.Leclercq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibition/Control.2</measure>
    <time_frame>At baseline</time_frame>
    <description>Stroop - GREFEX (2001)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vigilance</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1) Zimmerman et Fimm (1994) French adaptation M.Leclercq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Memory learning.</measure>
    <time_frame>At baseline</time_frame>
    <description>RL-RI 16 (French adaptation of Free and Cued Selective Reminding) GROBER &amp; BUSCKE (1987)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Working memory.1</measure>
    <time_frame>At baseline</time_frame>
    <description>WAIS working memory figure - Wechsler Adult Intelligence Scale (WAIS IV)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Working memory.2</measure>
    <time_frame>At baseline</time_frame>
    <description>TAP Test of Attentional Performance (TAP2.3.1)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Verbal Fluency</measure>
    <time_frame>At baseline</time_frame>
    <description>Verbal Fluency Test - Cardebat et al. (1990)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data processing speed</measure>
    <time_frame>At baseline</time_frame>
    <description>WAIS Symbols - Wechsler Adult Intelligence Scale (WAIS IV)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Psychological and Social Consultation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Psychological and Social Consultation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychological and Social Consultation</intervention_name>
    <description>Psychological and Social Consultation at Baseline, during the study and at the end of follow-up</description>
    <arm_group_label>Psychological and Social Consultation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients attending the Institut Bergonié

          -  Informed Consent signed.

          -  Patients affiliated to a French social

          -  living in Gironde

          -  Professional activity at the time of diagnosis

          -  Treated for - breast cancer, Hodgkin's or non-Hodgkin's lymphoma (non-cerebral),
             testicular cancer

          -  CURATIVE support

          -  At any time during treatment (chemotherapy or radiotherapy, or immunotherapy)

        Exclusion Criteria:

          -  Patient deprived of liberty or subject to a legal protection measure

          -  History of cancers

          -  Cerebral pathology and / or brain metastasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Véronique GERAT-MULLER, PhD</last_name>
    <phone>+556333333</phone>
    <email>v.gerat-muller@bordeaux.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Simone MATHOULIN-PELISSIER, MD,PhD</last_name>
    <email>s.mathoulin@bordeaux.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique GERAT-MULLER, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Véronique GERAT-MULLER, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guilaine WILKINS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oncology</keyword>
  <keyword>Work Keeping</keyword>
  <keyword>Social difficulties</keyword>
  <keyword>Cognitive Disorders</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

